One-stage and Delayed Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography with Endoscopic Sphincterotomy in Cholecystocholedocholithiasis
1 other identifier
observational
44
1 country
1
Brief Summary
In this study, it is planned to compare ERCP with ES + delayed LC in children, with one-stage LC + ERCP with ES in adults to confirm that ERCP with ES + delayed LC is more suitable for pediatric patients with cholecystocholedocholithiasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
November 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2025
CompletedMarch 10, 2025
March 1, 2025
3 months
October 27, 2024
March 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence of stones in the common bile duct
The diagnosis of the stone in the common bile duct.
30 days after ERCP
Secondary Outcomes (10)
Bleeding
30 days after ERCP
Perforation
30 days after ERCP
Bile leak
30 days after ERCP
Acute cholangitis
60 days after ERCP
Bile duct stricture
1 year after ERCP
- +5 more secondary outcomes
Study Arms (2)
ERCP, EST and simultaneous LC
Patients aged 10-80 years initially underwent ERCP with ES by an endoscopist with the consent of the patient or legal representative. Patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Laparoscopic cholecystectomy was performed immediately after ERCP with ES under general anesthesia
ERCP, EST and LC in a delayed manner
Patients aged 0-17 years initially underwent ERCP with ES by an endoscopist with the consent of the patient or legal representative. Patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Laparoscopic cholecystectomy was performed in a delayed manner, not earlier than 7 days after ERCP
Interventions
Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed immediately after ERCP with ES under general anesthesia.
Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patient underwent the endoscopic procedure using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed on a delayed basis no earlier than 7 days after ERCP
Eligibility Criteria
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
You may qualify if:
- Informed consent from the patient, child or legal representative
- Age 0-80 years
- Acute cholecystitis
- Choledocholithiasis
- Intraoperative ERCP
- Preoperative ERCP followed by cholecystectomy
You may not qualify if:
- Unwillingness or inability to consent to the study
- Pregnancy
- Age \> 80 years
- Previous ERCP or percutaneous transhepatic biliary drainage
- Anastomosis in the upper gastrointestinal tract
- Benign or malignant stricture
- Preoperative comorbidities: gastrointestinal bleeding, severe liver disease, acute and chronic cholangitis, other known cholestatic hepatopancreatobiliary disease, septic shock.
- In combination with Mirizzi syndrome and intrahepatic bile duct stones
- Congenital anomaly of the biliary tract
- Malignant neoplasms
- Acute pancreatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Moscow, Moscow Oblast, 142636, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dmitriy А Pyhteev, PhD
Head of the Department of Pediatric Surgery
- PRINCIPAL INVESTIGATOR
Leonid M Elin
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2024
First Posted
November 6, 2024
Study Start
November 13, 2024
Primary Completion
February 20, 2025
Study Completion
March 5, 2025
Last Updated
March 10, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
A complete dataset can be provided upon reasoned request